Exome Asset Management is a venture debt provider. Based in New York, United States. Known portfolio companies include Broncus Technologies, NextCure, Aprea, I-Mab Biopharma, Gracell Biotechnologies and IMPACT Therapeutics, 8 companies in all.
Is Exome Asset Management a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- GrowthLate-StageSeed
- Sector
- Healthcare
Exome Asset Management portfolio companies (8)
- Broncus Technologies
- NextCure
- Aprea
- I-Mab Biopharma
- Gracell Biotechnologies
- IMPACT Therapeutics
- New Horizon Health
- Centrexion Therapeutics
Co-investors
Funds that share portfolio companies with Exome Asset Management.
Similar funds
Showing 20 of 100
About Exome Asset Management
The firm's listing covers sector Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and Emerging Markets; known deals cluster at Growth, Late-Stage and Seed.
Across the known portfolio, 14 co-investors appear alongside Exome Asset Management, including Intuitive, Tally Capital and Dafna Capital Management.
Frequently asked questions
What is Exome Asset Management?
Exome Asset Management is a venture debt provider based in New York, United States, with a known portfolio of 8 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Exome Asset Management invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and Emerging Markets. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Exome Asset Management invest at?
The known deals of Exome Asset Management include Growth, Late-Stage and Seed rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact Exome Asset Management?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal